Blood Genomic Signature (BGS) Test


Early Cancer Risk Detection

The BGS test is a non-invasive blood test that uses circulating RNA in the blood to screen an individual’s current risk for a panel of 8 cancers.




Cancer Risk Detection Lung Cancer
Colorectal Cancer
Liver Cancer
Stomach Cancer
Nasopharyngeal Cancer
Prostate Cancer – for male
Breast Cancer – for female
Cervical Cancer – for female
Other Diseases Crohn’s Disease
Ulcerative Colitis
Medical Review Results Interpretation by Medical Officer

There are no reviews yet.

Be the first to review “Blood Genomic Signature (BGS) Test”

Your email address will not be published. Required fields are marked *